Semaglutide and the risk of diabetic retinopathy—current perspective

Authors :: Nikulaa Parachuri
Nilesh Kumar
Bharat Saboo
Francesco Bandello
Baruch D. Kuppermann
Ashish Sharma
Hridaya Nath Tripathi
Source :: Eye (Lond)
Publication Year :: 2021
Publisher :: Nature Publishing Group UK, 2021.

Subjects :: medicine.medical_specialty
Diabetic Retinopathy
business.industry
Semaglutide
Perspective (graphical)
Comment
MEDLINE
Glucagon-Like Peptides
Diabetic retinopathy
medicine.disease
Ophthalmology
Diabetes Mellitus, Type 2
medicine
Humans
Hypoglycemic Agents
Intensive care medicine
business

Tools